TCL Archive Taxol Approved By FDA For Ovarian Cancer; Bristol Sets Price Tier In Line With Platinum January 8, 1993
TCL Archive Somatuline Demonstrates 65.1 Percent Of Patients Progression-Free at 96 Weeks July 25, 2014
